Cargando…
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
The Chinese hamster ovary (CHO) cell line is a well-established platform for the production of biopharmaceuticals due to its ability to express complex therapeutic proteins with human-like glycopatterns in high amounts. The advent of CRISPR technology has opened up new avenues for the engineering of...
Autores principales: | Glinšek, Katja, Bozovičar, Krištof, Bratkovič, Tomaž |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179654/ https://www.ncbi.nlm.nih.gov/pubmed/37175850 http://dx.doi.org/10.3390/ijms24098144 |
Ejemplares similares
-
Evolving a Peptide: Library Platforms and Diversification Strategies
por: Bozovičar, Krištof, et al.
Publicado: (2019) -
Small and Simple, yet Sturdy: Conformationally Constrained Peptides with Remarkable Properties
por: Bozovičar, Krištof, et al.
Publicado: (2021) -
Multiplex Genome Editing in Chinese Hamster Ovary Cell Line Using All-in-One and HITI CRISPR Technology
por: Safari, Fatemeh, et al.
Publicado: (2021) -
Focused peptide library screening as a route to a superior affinity ligand for antibody purification
por: Bozovičar, Krištof, et al.
Publicado: (2021) -
Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells
por: Zhang, Huan-Yu, et al.
Publicado: (2021)